Tesa Medical
Early Stage
Enabling rapid soft tissue tensioning and fixation
Overview
Platform
RedCrow
Start Date
08/04/2022
Close Date
12/31/2023
Min. Goal
$20,000
Max. Goal
$500,000
Min. Investment
$0
Security Type
Convertible Note
Series
Pre-Seed
SEC Filing Type
RegD 506(b)
Valuation Cap
$5,000,000
Discount
20%
Year Founded
2009
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2C
Margin
Low
Capital Intensity
High
Tesa Medical, with a valuation of $5 million, is raising funds on RedCrow through Reg D 506(b) raise. It is a medical device company enabling rapid soft tissue tensioning and fixation. The patented technology of Test Medical, CordaSet, enables physicians to mitigate downstream consequences for ACL reconstruction procedures through rapid tensioning and fixation of soft tissues. The CordaSet system gives the physicians the ability to adjust graft tension without damaging the graft. Howard Edelman founded Tesa Medical in 2009. The current crowdfunding campaign has a minimum target of $20,000 and a maximum target of $500,000. The campaign proceeds will be used to finalize system beta development and file additional IPs.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.